News About: Pharm. Affairs
Will Hanmi Pharm monopolize the antismoking cessation market after winning the patent trial against ‘Champix’?The government has promoted antismoking by providing antismoking wishers financial supports on maximum 6 sessions of smoking cessation counseling within 12 weeks and antismoking...
|
The Supreme Court nullified the Viagra’s use patent, accepting dismissal of the Pfizer’s appeal
The Supreme Court made the final decision that the use patent of the impotency treatment ‘Viagra’ is invalid. Thus, generic companies have gotten away from damage suits.
The Second Special Department of the Supreme C...
Generics of the top lung cancer treatment will appear, decreasing the overall drug price down by 38% for the disease
As the patent of the most selling lung cancer treatment ‘Alimta(Lilly Korea)’ will expire on the 10th next month, generic products with the same substance are about make sales.
It seems that generics, having 38% chea...
The golden age of DDP-4 continuing high-speed growth along with its complexes
In the diabetes treatment market, DPP-4 is making high-speed growth. It is also observed that the switching is currently on procedure after launches of generics.
According to the Medipana News’s analysis result of ou...
Consecutive drug price reductions of hyperlipidemia treatments, setting the price competition
The price has been magnified from the competition among hyperlipidemia treatments as launches of new drug and the drug price reduction.
According to the recent official announcement of the Health and Welfare, the cei...
Pharmaceutical exports hit the highest ever on March, along with expansion of domestic new drugs against foreign ones
As the pharmaceutical exportation recorded the largest ever with $250.62 million on the last March, it increased 72.8% up compared to the same month of the last year.
According to the Shinhan Investment on the 21st, ...
While hyperlipidemia treatments have hesitated, hypertension and antithrombotic treatments are showing contradict performance
Among cardiovascular drugs encountered contradict situations. Although outpatient prescriptions of hypertension treatments (ARB type) increased narrowly, hyperlipidemia and antithrombotic treatments drew significant i...
Pharmacists stepping in promotion, “Don’t you misunderstand for the cervical cancer vaccine”
Although ‘adult vaccines’ have become the new profit sources in local clinics, there is a type of a vaccine that troubles pharmacists from its promotion due to misunderstandings and fears. The vaccine is a vaccine for...
Competition will get severe between Viread and Baraclude
Expected to be applied for the insurance benefit on the solo therapy for multiple drug resistant patients, the Gilead’s hepatitis type B treatment, Viread (tenofovir), has kept its increasing curve.
It is expected th...
Launches of complexes and generics is about to change the statin market
‘Lipitor (atorvastatin)’ and ‘Crestor (generic name: rosuvastatin)’, which have divided the hyperlipidemia treatment market into tow, encountered the situation to defend attacks of complexes and generics this year and...
